![Foto de José Federico](/img/nophoto.png)
José Federico
Díaz González
Catedrático de Universidad
Publicaciones (149) Publicaciones de José Federico Díaz González
2024
-
Early identification of golimumab-treated patients with higher likelihood of long-term retention
Frontiers in Immunology, Vol. 15
-
Management, development and methodology of the Clinical Practice Guidelines and Recommendations of the Spanish Society of Rheumatology
Reumatologia Clinica, Vol. 20, Núm. 7, pp. 392-397
-
Modulation of the K/BxN arthritis mouse model and the effector functions of human fibroblast-like synoviocytes by liver X receptors
European Journal of Immunology
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
-
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892
-
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 587-598
-
The complement system is linked to insulin resistance in patients with systemic lupus erythematosus
Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121
2023
-
Development of a web tool to calculate the cumulative dose of glucocorticoids
Reumatologia Clinica, Vol. 19, Núm. 1, pp. 1-5
-
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
The Lancet Regional Health - Europe, Vol. 33
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Expert recommendations for the use of apremilast in psoriatic arthritis
Reumatologia Clinica, Vol. 19, Núm. 1, pp. 34-44
-
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Advances in Rheumatology, Vol. 63, Núm. 1
-
Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
Frontiers in Immunology, Vol. 14
-
HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
-
Rheumatoid arthritis
Medicina Clinica, Vol. 161, Núm. 12, pp. 533-542
-
Tocilizumab-related hypertriglyceridemia is independent of key molecules regulating lipid metabolism
European Journal of Clinical Investigation, Vol. 53, Núm. 9
2022
-
Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases
Joint Bone Spine, Vol. 89, Núm. 1
-
Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables
Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096
-
Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis
Journal of immunology (Baltimore, Md. : 1950), Vol. 209, Núm. 1, pp. 38-48